ERP-based Detection of Brain Pathology in Rat Models for Preclinical Alzheimer's Disease


Book Description

Early pathological features of Alzheimer's disease (AD) include the accumulation of hyperphosphorylated tau protein (HP-tau) in the entorhinal cortex and progressive loss of basal forebrain (BF) cholinergic neurons. These pathologies are known to remain asymptomatic for many years before AD is clinically diagnosed; however, they may induce aberrant brain processing which can be captured as an abnormality in event-related potentials (ERPs). Here, we examined cortical ERPs while a differential associative learning paradigm was applied to adult male rats with entorhinal HP-tau, pharmacological blockade of muscarinic acetylcholine receptors, or both conditions. Despite no impairment in differential associative and reversal learning, each pathological feature induced distinct abnormality in cortical ERPs to an extent that was sufficient for machine classifiers to accurately detect a specific type of pathology based on these ERP features. These results highlight a potential use of ERPs during differential associative learning as a biomarker for asymptomatic AD pathology.




Investigating the Role of Age, Sex, and Alzheimer's Disease Pathology on Neurochemical and Neuroanatomical Trajectories Throughout the Rat Lifespan


Book Description

"Alzheimer's disease (AD) is a progressive and irreversible neurodegenerative disorder that accounts for 60-80% of the 50 million dementia cases worldwide. The most widely accepted risk factor for developing AD is age. The distinction between aging and AD is particularly crucial during the early stages of disease progression since this is when intervention is most likely to be effective. However, there is a lack of biological markers capable of identifying early-stage AD, limiting opportunities for diagnosis and treatment. Comprehensive characterization of aging and disease processes in relevant animal models represents one promising avenue towards developing options for diagnosis and treatment. In particular, longitudinal preclinical studies that employ techniques with high translational potential to clinical studies, such as non-invasive neuroimaging techniques, would enable identification of homologous biomarkers across species. The content of this thesis describes the application of whole-brain MRI and localized MRS to investigate age- and sex-related changes in neurochemistry and neuroanatomy in a commonly used rat model of aging (the Fischer 344 rat), and the subsequent integration of these techniques with behavioural testing in a transgenic rat model developed on a Fischer 344 background to distinguish the effects of aging versus Alzheimer's disease pathology on neuroimaging and cognitive markers. Chapters 1 and 2 provide a general introduction and background information on the current state of knowledge regarding the impact of age and AD pathology on brain structure and tissue chemistry, as well as the neuroimaging and statistical methods used to investigate these neurobiological changes. Chapter 3 presents a published study examining age- and sex-related changes in hippocampal biochemistry in the Fischer 344 rat. Age was associated with prominent differences in metabolites implicated in anaerobic energy metabolism, antioxidant defenses, and neuroprotection, as well as numerous macromolecule changes. Chapter 4 builds upon the previous study of highly localized effects of aging by examining whole-brain volumetric changes associated with age and sex, again in the Fischer 344 rat. This publication identifies age- and sex-related volume changes in regions such as the cortex, hippocampus, cingulum, caudoputamen, and nucleus accumbens, which are implicated in memory and motor control circuits frequently affected by aging and neurodegenerative disease. Chapter 5 incorporates the techniques and knowledge developed in earlier chapters by applying the same neuroimaging techniques in combination with behavioural testing in a transgenic model of Alzheimer's disease developed on a Fischer 344 background, the TgF344-AD rat. The TgF344-AD model demonstrated impaired spatial reference memory by 4 months of age, followed by neurochemical abnormalities by 10 months and major structural changes by 16 months, many of which were similar to findings in human Alzheimer's disease subjects. A mild influence of sex was also seen on neuroimaging and cognitive markers. Finally, Chapter 6 provides a discussion and summary of the relevance of these findings. Altogether, this thesis describes the application of highly translatable neuroimaging techniques to identify multiple neurobiological features influenced by age-, sex-, and pathology throughout the lifespan of two relevant rat models. This thesis therefore provides support for the use of MRI and MRS in rodent models in vivo to develop markers of pathological change which may be used to improve age- and disease-related outcomes in humans"--




The Oxford Handbook of Event-Related Potential Components


Book Description

The Oxford Handbook of Event-Related Potential Components provides a detailed and comprehensive overview of the major ERP components. It covers components related to multiple research domains, including perception, cognition, emotion, neurological and psychiatric disorders, and lifespan development.







Biomedical Engineering, Trends in Electronics


Book Description

Rapid technological developments in the last century have brought the field of biomedical engineering into a totally new realm. Breakthroughs in material science, imaging, electronics and more recently the information age have improved our understanding of the human body. As a result, the field of biomedical engineering is thriving with new innovations that aim to improve the quality and cost of medical care. This book is the first in a series of three that will present recent trends in biomedical engineering, with a particular focus on electronic and communication applications. More specifically: wireless monitoring, sensors, medical imaging and the management of medical information.




Neuroimaging in Psychiatry


Book Description

New neuroimaging techniques are developing at a break neck pace-every academic journal contains glossy pictures of brain activity corresponding to a particular task emblazoned in glorious technicolor. Discoveries about brain function in psychiatric disorders have been made at an equally rapid rate. However, most books on the subject have been written from a technical point of view. An introductory, easy-to-read guide, Neuroimaging in Psychiatry provides an overview and the clinical relevance of the latest neuroimaging findings. With contributions from an international panel of experts, this book reviews current findings from neuroimaging in schizophrenia, obsessive-compulsive disorder, depression, eating disorders, psychopathy, aging, and drug addiction. Chapter authors explore innovative and imaginative uses of neuro imaging technology, implications for our understanding of these disorders, and their impact on clinical practice. The book gives you a general overview of the main techniques to help you successfully complete a neuroimaging project.




Human and Animal Models for Translational Research on Neurodegeneration: Challenges and Opportunities From South America


Book Description

Neurodegenerative diseases are the most frequent cause of dementia, representing a burden for public health systems (especially in middle and middle-high income countries). Although most research on this issue is concentrated in first-world centers, growing efforts in South America are affording important breakthroughs. This emerging agenda poses new challenges for the region but also new opportunities for the field. This book aims to integrate the community of experts across the globe and the region, and to establish new challenges and developments for future investigation. We present research focused on neurodegenerative research in South America. We introduce studies assessing the interplay among genetic, neural, and behavioral dimensions of these diseases, as well as articles on vulnerability factors, comparisons of findings from various countries, and works promoting multicenter and collaborative networking. More generally, our book covers a broad scope of human-research approaches (behavioral assessment, neuroimaging, electromagnetic techniques, brain connectivity, peripheral measures), animal methodologies (genetics, epigenetics, proteomics, metabolomics, other molecular biology tools), species (all human and non-human animals, sporadic, and genetic versions), and article types (original research, review, and opinion papers). Through this wide-ranging proposal, we hope to introduce a fresh approach to the challenges and opportunities of research on neurodegeneration in South America.




Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System


Book Description

Glutamate is the most pervasive neurotransmitter in the central nervous system (CNS). Despite this fact, no validated biological markers, or biomarkers, currently exist for measuring glutamate pathology in CNS disorders or injuries. Glutamate dysfunction has been associated with an extensive range of nervous system diseases and disorders. Problems with how the neurotransmitter glutamate functions in the brain have been linked to a wide variety of disorders, including schizophrenia, Alzheimer's, substance abuse, and traumatic brain injury. These conditions are widespread, affecting a large portion of the United States population, and remain difficult to treat. Efforts to understand, treat, and prevent glutamate-related disorders can be aided by the identification of valid biomarkers. The Institute of Medicine's Forum on Neuroscience and Nervous System Disorders held a workshop on June 21-22, 2010, to explore ways to accelerate the development, validation, and implementation of such biomarkers. Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System: Workshop Summary investigates promising current and emerging technologies, and outlines strategies to procure resources and tools to advance drug development for associated nervous system disorders. Moreover, this report highlights presentations by expert panelists, and the open panel discussions that occurred during the workshop.




Encyclopedia of Neuroscience, Volume 1


Book Description

The Encyclopedia of the Neuroscience explores all areas of the discipline in its focused entries on a wide variety of topics in neurology, neurosurgery, psychiatry and other related areas of neuroscience. Each article is written by an expert in that specific domain and peer reviewed by the advisory board before acceptance into the encyclopedia. Each article contains a glossary, introduction, a reference section, and cross-references to other related encyclopedia articles. Written at a level suitable for university undergraduates, the breadth and depth of coverage will appeal beyond undergraduates to professionals and academics in related fields.




Cognitive Plasticity in Neurologic Disorders


Book Description

This volume makes clear that the cognitive and behavioural symptoms of neurologic disorders and syndromes are dynamic and changing. Each chapter describes the neuroplastic processes at work in a particular condition, giving rise to these ongoing cognitive changes.